喜见同济老同学获得美国杰出科学奖

俄亥俄州立大学教授向惠云。

我在同济的老同窗向惠云近日获得了一个美国全国性的科学奖,昨天我花时间将获奖词翻成了中文,现在身材也与成就相当的老同学还提供了照片,让我们可以在此分享和道贺。同济以医学闻名,出过很多名医,我也有说不完的同济故事,但是或许大家不太知晓的事实是同济的公共卫生学院常年名列中国的第一名。 向惠云就是我们公卫学院的杰出代表之一,同济产生的唯一美国院士哈佛教授胡丙长也是公卫学院的毕业生,他们还是同届的同窗,看来教那届的同济教授们应该受到嘉奖。我能称向惠云为同学是因为我们研究生在一起,虽然我本科是学临床医学的。

中国人在美国获得全国性的学术奖励是件非常不容易的事情,发生在老同学的身上更是令人高兴。在任何科学领域获得同行的肯定对于评价学术成就是最有说服力的,同行可能是朋友也可以是尖锐的批评者,因为现代科学分枝细到可以令外行像听天书的程度,所以我昨天翻译完后的专业术语和表述只能请专家定稿, 因为我略懂得炎症导致的细胞损伤,但是对急症室创伤的统计学模型则一无所知。惠云在科罗拉多获得的博士,现在工作的属于俄亥俄州立大学的全美儿童医院为重要的研究中心。最近他们跑来圣路易斯挖人,把华盛顿大学全球闻名的基因组研究所的两位共同所长延聘,这将是对新上任不久的医学院院长的巨大挑战。

让我们在这里以向恵云教授的答谢词的中文翻译结束,再次向老同学道贺:“我怀着感恩与谦卑的心情接受2016年的APHA ICEHS的杰出科学奖。这个荣誉确切地说属于我的富有活力的研究团队,属于那些数不尽的与我合作过的优秀专家,许多导师和全美儿童医院的领导更是在我几次的困难时期提供了无私的参谋和一如既往地支持和信任。没有你们的帮助和支持,我不可能走得这么远和获得此奖项。为此,我感谢所有人。”

向恵云教授答谢词的英文原稿。

圣路易斯华大基因组研究所共同所长Richard Wilson和Elaine Mardis。他们将在今年九年去俄亥俄的全美儿童医院任职,俄亥俄用一千万美元吸引他们离开,似乎钱也不是太多。Wilson在基因测序的标志性人物 Robert Waterston离开后执掌华大基因组计划,成为引用率最高的科学家之一,并且与医生合作开创了癌症和其他基因组计划。

下面为颁奖机构的英文和我的翻译稿:

美国公共卫生协会杰出科学奖

(官方获奖词中文翻译校定稿,7/14/2016)

American Public Health Association Excellence in Science Award: To recognize an individual, frequently at mid-career, for outstanding dedication and leadership in the science of injury/violence prevention and control and emergency health services with contributions and achievements that have a significant and long term impact on the field. Recipient must be a section member.

美国公共卫生协会杰出科学奖:该奖通常授予职业中期的一位杰出人士,表彰他们在伤害和暴力预防和控制以及急症医学等科学领域的杰出奉献和领袖才能,获奖者的贡献和成就必须对这些学术领域具有长久的影响力。获奖者必须是该协会的一个分会的会员。

WINNER—Huiyun Xiang MD, MPH, PhD, Professor, Center for Injury Research and Policy, Research Institute at Nationwide Children’s Hospital

获奖者-向惠云博士,俄亥俄州立大学医学院-全美儿童医院伤害研究和政策研究中心教授

Dr. Huiyun Xiang is a Professor of Pediatrics at The Ohio State University College of Medicine. He holds a joint appointment at the Division of Epidemiology, The Ohio State University College of Public Health. Dr. Xiang is currently the Director of the Center for Pediatric Trauma Research at Nationwide Children’s Hospital, the Director of International Programs and the Director of Research Core at the Center for Injury Research and Policy (CIRP), The Research Institute at Nationwide Children’s Hospital. His primary research interests include injury and safety research in individuals with disabilities, pediatric trauma emergency health services research, and innovative injury research methodology. His work has been continuously funded by state and federal grants since 2003. He has published more than 160 peer-reviewed journal articles and 2 book chapters, and he has presented his research findings at a variety of conferences around the world.

向惠云博士是俄亥俄州立大学医学院的儿科教授,他同时在俄亥俄州立大学公共卫生学院的流行病学系任教授。向博士目前是全美儿童医院小儿创伤研究中心主任,也是伤害研究和政策中心(CIRP)国际交流部主任和研究部主任,该中心设在全美儿童医院的研究所内。他的主要研究兴趣包括对残疾人的伤害和安全的研究、儿童外伤急救卫生服务以及创新型创伤研究方法学的研究。自2003年以来,他的工作持续获得州和联邦政府的资助; 他在同行评议的杂志上发表了超过160篇的研究论文和2篇专著的章节,并且多次在众多世界学术会议上交流研究成果。

Dr. Xiang has made significant contributions to the field of injury and violence prevention. One of these contributions is reflected in his work on injuries among individuals with disabilities. In 2010, he served as an injury expert in the U.S. Department of Health and Human Services’ Healthy People 2020 Initiative for the Disability and Health Workgroup. Using his expertise in this area, he collaborated with other experts to propose a new Healthy People 2020 Objective (DH-19, Developmental) to reduce health disparities and address health issues facing individuals with disabilities who have suffered nonfatal unintentional injuries. The proposed objective of reducing injuries among individuals with disabilities has officially become one of the Healthy People 2020 objectives. For the first time in history, an objective to reduce the proportion of people with disabilities who experience nonfatal unintentional injuries that require medical care was added to the national Healthy People prevention effort in 2011.

向博士在伤害和暴力预防领域做出了显著的贡献,这些贡献尤其体现在他对残疾人士伤害的研究工作。 在2010年他作为伤害专家参加了由美国卫生和国民服务部牵头举办的“面向残疾和健康人群的2020规划”。利用他在这方面的专长,他与其他专家合作,提出了一个新的健康人民2020年规划(DH-19,发展纲要),目的为减少不同人群的健康差距,直接探讨那些受非致命非故意伤害困扰的残疾人所面临的健康问题。关于预防残障人的伤害的提案已经正式成为健康人2020年规划的目标之一。作为历史上的首次,以减少那些受非致命非故意伤害影响的残疾人的比例的提案被纳入在2011实施的全美国健康人规划。

Dr. Xiang’s research is also recognized internationally. The World Health Organization and the World Bank released its first-ever World Report on Disability in 2011. This report featured Dr. Xiang’s research and provided a concrete set of recommended actions for governments and their partners. His work on disabilities and injuries also informed a special symposium entitled “Should “Disability Status” Be a Covariate in Most Epidemiological Research?” at the World Congress of Epidemiology, June, 2011 in Montreal, Canada. Papers presented during this symposium were published as a special topic in the Annals of Epidemiology in 2014 which included two of Dr. Xiang’s publications, one from the US and one published with colleagues in China. Further, the symposium was so well received that the presenters, including Dr. Xiang, were invited to give the same presentations at a seminar at the Centers for Disease Control and Prevention in Atlanta, which was broadcast throughout the US.

向博士的研究得到了国际同行的认可。世界卫生组织和世界银行在2011年发布了首个关于残疾人的世界报道,这份报告重点介绍了向博士的研究,并且认为他的研究对政府和政府伙伴的决策具有坚实的参考基础。他的关于残疾和伤害的工作还成为一个名为“残疾是否 应该成为常规流行病学研究的协变量?”的专题讨论会,该专题是2011年6月在加拿大蒙特利尔举行的的世界流行病大会的一部分。本次研讨会期间提交的论文 被汇总发表在2014年的流行病学年鉴上,包括向博士与美国和中国合作者的两篇论文。该专题讨论会的反响良好,包括向博士在内的报告者随后被邀请去亚特兰大的疾病控制中心做报告,并且报告的视频在全美范围内分享。

Using a multidisciplinary approach, Dr. Xiang and his team conduct numerous innovative projects that assess how pre hospital emergency medical services, acute medical and surgical management, rehabilitation, and family and community services impact the short and long-term outcomes of injured patients. Funded by the Agency for Healthcare Research and Quality, Health Resources and Services Administration, and the Ohio Department of Public Safety Emergency Medical Service, Dr. Xiang and his team evaluate regionalized trauma systems and under-triage of major trauma patients in the US. Their findings have important implications for trauma system quality improvement and mortality risk reduction at non-trauma and level III trauma medical settings. Dr. Xiang and his team always strive for excellence in rigorous research methodology. He and his collaborators have developed novel research methodology for pediatric trauma and emergency health services, including assessing emergency department mortality at three different levels of trauma centers and evaluating unmeasured confounding factors in observational studies with multiple patient treatment groups using triplet matching followed with sensitivity analysis. While developed for trauma outcomes research, these methodology and techniques are applicable to study other health problems.

应用多学科的方法,向博士和他的团队设计出创新性的研究方案,去研究评估进医院前的急症医疗服务、急症医疗与外科处理、康复、以及家庭和社区服务对伤害病人的短期和长期的影响。向博士的研究得到美国卫生和人类服务部-保健研究和质量局(Agency for Healthcare Research and Quality),卫生资源和服务部局(Health Resources and Services Administration)以及俄亥俄公共安全和急症医疗服务部的多项资助。向博士和他的团队评估美国区域性创伤救治系统和美国对重症伤害病人及时分诊的不足与后果。他们的研究结果对于美国区域性创伤救治系统中非创伤系统医疗机构和低级别创伤救治医疗机构如何提高医疗质量和降低死亡率具有重要的意义。向博士和他的团队始终追求卓越的严谨研究方法。他和他的合作者已经创立了创伤和急救医疗服务的崭新研究方法,包括评估三个不同层次的创伤救治中心的急症室的死亡率及应用生物统计学敏感性分析方法去评估临床观察研究中的不可测的混杂因素对于研究结果的影响。虽然这些研究方法是为评估创伤治疗效果而创立的,但是这些研究方法和技术可应用于研究其他的健康问题。

In addition to his pioneering work in injury and trauma research, Dr. Xiang has served in many national and international leadership roles and made significant contributions to the injury and trauma research in the US and around the world.

除了他自己在伤害和创伤研究的开拓性的工作外,向博士还曾在许多美国和世界的专业领域担任领导角色,并且对美国和世界其他地方的伤害和创伤研究做出了显著的贡献。

雅美之途 发表评论于
上海二医并入交大,上海同济并了铁道医学院。同济医科大学并入华中科技大学。
o,dear 发表评论于
恭喜非凡成就。是以前上海二医并入同济大学的吗?
闲闲客 发表评论于
恭喜!
诚信 发表评论于
Congratulations! Great achievement.
登录后才可评论.